Evidence map›Paper›PMID 35630398›Full record

ArticleMicroorganisms2022

Identification, Biochemical Characterization, and Safety Attributes of Locally Isolated

Sana Abid, Arshad Farid, Rameesha Abid, Mujeeb Ur Rehman, Walaa F Alsanie, Majid Alhomrani, Abdulhakeem S Alamri, Syed Mohammed Basheeruddin Asdaq, Daniel Ingo Hefft, Saddam Saqib and 4 more

Abstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Lactiplantibacillus plantarum as a sustainable solution for monocrotophos degradation and plant growth enhancement.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  7. International journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Innovative use of indigenousVeterinary world · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Clinical trials of probiotics: Current outlook.Food science & nutrition · 2024
    Article
  18. Article
  19. Isolation andFrontiers in microbiology · 2024
    Article
  20. Characterization ofInternational journal of microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sana AbidDepartment of Biology, Faculty of Science & Technology, Virtual University, Lahore 54000, Pakistan.
Arshad FaridGomal Centre of Biochemistry and Biotechnology, Gomal University, D.I.Khan 29050, Pakistan.ORCID 0000-0001-5147-5936
Rameesha AbidDepartment of Biotechnology, University of Sialkot, Sialkot 51310, Pakistan.ORCID 0000-0002-0464-5477
Mujeeb Ur RehmanDepartment of Pharmacy, Quaid-i-Azam University, Islamabad 45500, Pakistan.ORCID 0000-0003-4633-5511
Walaa F AlsanieDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Al Hawiyah 21944, Saudi Arabia.
Majid AlhomraniDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Al Hawiyah 21944, Saudi Arabia.ORCID 0000-0001-9798-0962
Abdulhakeem S AlamriDepartment of Clinical Laboratory Sciences, The Faculty of Applied Medical Sciences, Taif University, Al Hawiyah 21944, Saudi Arabia.ORCID 0000-0003-3174-0434
Syed Mohammed Basheeruddin AsdaqDepartment of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah 13713, Saudi Arabia.ORCID 0000-0003-1533-9667
Daniel Ingo HefftReaseheath College, University Centre Reaseheath, Nantwich CW5 6DF, UK.ORCID 0000-0002-0775-7538
Saddam SaqibDepartment of Biotechnology, Mohi- ud-Din Islamic University, Nerian Sharif 12080, Pakistan.ORCID 0000-0002-1240-8949
Muhammad MuzammalGomal Centre of Biochemistry and Biotechnology, Gomal University, D.I.Khan 29050, Pakistan.
Sabrin Abdelrahman MorshedyFish and Animal Production Department, Faculty of Agriculture (Saba Basha), Alexandria University, Alexandria 21526, Egypt.ORCID 0000-0002-9389-9259
Mashael W AlruwaysDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra 15273, Saudi Arabia.
Shakira GhazanfarNational Institute of Genomics and Advanced Biotechnology (NIGAB), National Agricultural Research Centre, Park Road, Islamabad 45500, Pakistan.ORCID 0000-0002-6277-5106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demand of functional foods is on the rise, and researchers are trying to develop nutritious dairy products by using well-characterized strains of bacteria. In this study, we identified locally isolated strains of Lactobacillus fermentum from Bubalus bubalis (Nilli Ravi buffalo) milk and evaluated their potential as probiotics in food products like fermented milk. Fifteen Lactobacillus strains were initially isolated, and only four strains (NMCC-2, NMCC-14, NMCC-17, and NMCC-27) were examined for morphological and biochemical characterizations due to their ability of gas production in Durham tubes. Moreover, these strains were selected for further probiotic characterizations due to their extreme morphological resemblance with lactic acid bacteria for their antimicrobial activity, enzymatic potential, autoaggregation capability, hydrophobicity, and acid and bile tolerance. All selected isolates showed significant probiotic potential. However, NMCC-14 and NMCC-17 strains showed maximum probiotic potential. The isolates (NMCC-2, NMCC-14, NMCC-17, and NMCC-27) were identified as Lactobacillus fermentum utilizing 16S rRNA gene sequencing. The in vivo safety study of NMCC-14 (dose: 1010 CFU/day/mice; 21 days, orally) showed no histological dysfunctions in a mouse model. Pathogenic bacterial enzymes reduced the beneficial bacterial load in the host gastrointestinal tract. These results suggest that the NMCC-14 strain is safe and can be potentially used as a probiotic. Moreover, fermented milk was prepared by using the NMCC-14 strain. The results revealed that NMCC-14 strain-based fermented milk had significantly (p < 0.05) higher protein content (4.4 ± 0.06), water-holding capacity (WHC), and dynamic viscosity as compared to non-fermented milk. The results suggest that L. fermentum NMCC-14 is safe and nontoxic; hence, it can be a beneficial supplement to be used for the development of dairy products to be subjected to further clinical testing.

Indexed as

fermented milkidentificationLactobacillus fermentumprobioticssafety attributes

Identifiers

PMID35630398
PMCPMC9144466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.